Xylem Q1 2026 Earnings EPS Slightly Above Estimates Amid Operational Strength Symbotic SYM Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Optimism OCS Q1 2026 Earnings WiderthanExpected Losses Amid Continued Pipeline Investment ST Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Gains Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development